Researcher

Kathrin Marx

Klinikum St. Georg

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 28, 2026 · JOURNAL ARTICLE

Real-World Therapy with Eravacycline for Complex Infections Caused by Carbapenem-Resistant Pathogens with a Focus on Patients with Severe Burns

Infectious Diseases and Therapy

Small retrospective single-centre case series (n=8) with no comparator, presenting observational real-world data on eravacycline safety and clinical outcomes in carbapenem-resistant infections; the authors themselves describe it as preliminary and lacking formal statistical power.

PreliminaryKathrin Marx Sven Kalbitz Christoph Lübbert

Reported

Clinical cure rate87.5% (7/8)

Microbiological pathogen eradicat…7/8 patients

Sample size8

JUL 31, 2026 · JOURNAL ARTICLE

Caseload, treatment diagnoses, and evaluation of clinical care concepts for infectious diseases at a municipal tertiary care hospital in Germany

Infection

Retrospective descriptive analysis of clinical characteristics and service utilization at a single institution; no comparator group, no intervention tested, and no clinical outcome measures reported beyond length of stay.

PreliminaryNils Kellner Nadja Herrmann Kathrin Marx

Reported

ID patients as proportion of all…11.5%

Sample size17878

Inpatient ID department treatment28.7% (5,135/17,878)